Orbimed Advisors LLC’s Prelude Therapeutics Inc Position
Does Orbimed Advisors LLC own Prelude Therapeutics Inc (PRLD)? Yes — 10.91M shares worth $37M (+0.74% of its 13F portfolio) as of Q1 2026.
Position Value
$37M
Q1 2026
Shares
10.91M
% of Portfolio
+0.74%
Quarters Held
23
currently held
Position History PRLD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 10.91M | $37M | +0.74% |
| Q4 2025 | 10.91M | $32M | +0.65% |
| Q3 2025 | 10.91M | $16M | +0.37% |
| Q2 2025 | 10.91M | $9M | +0.22% |
| Q1 2025 | 10.91M | $8M | +0.20% |
| Q4 2024 | 10.91M | $14M | +0.29% |
| Q3 2024 | 10.91M | $23M | +0.41% |
| Q2 2024 | 10.91M | $42M | +0.82% |
| Q1 2024 | 10.91M | $52M | +0.95% |
| Q4 2023 | 10.91M | $47M | +0.93% |
| Q3 2023 | 10.91M | $34M | +0.72% |
| Q2 2023 | 10.91M | $49M | +0.89% |
| Q1 2023 | 10.04M | $57M | +1.12% |
| Q4 2022 | 10.04M | $61M | +1.16% |
| Q3 2022 | 10.04M | $66M | +1.23% |
| Q2 2022 | 10.04M | $52M | +0.95% |
| Q1 2022 | 10.04M | $69M | +1.12% |
| Q4 2021 | 10.04M | $125M | +1.61% |
| Q3 2021 | 10.04M | $314M | +3.45% |
| Q2 2021 | 10.04M | $287M | +2.91% |
| Q1 2021 | 10.04M | $435M | +4.07% |
| Q4 2020 | 15.59M | $1.1B | +9.76% |
| Q3 2020 | 15.59M | $470M | +5.91% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of PRLD.